NextCure, Inc.
NextCure, a biopharmaceutical company based in Beltsville, Maryland, supports clinical development of LNCB74 and manages transition of patients from the SIM0505 study while pursuing partnerships or licensing of legacy clinical and preclinical assets.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 10Latest story
November 2026
October 2026
August 2026
July 2026